SUBCORTICAL DOPAMINE AND SEROTONIN TURNOVER DURING ACUTE AND SUBCHRONIC ADMINISTRATION OF TYPICAL AND ATYPICAL NEUROLEPTICS

被引:34
作者
CSERNANSKY, JG
WRONA, CT
BARDGETT, ME
EARLY, TS
NEWCOMER, JW
机构
[1] Department of Psychiatry, Washington University School of Medicine, St Louis, 63110, MO
关键词
DOPAMINE; SEROTONIN; NEUROLEPTICS; CLOZAPINE; SULPIRIDE; 3-PPP; HALOPERIDOL;
D O I
10.1007/BF02246964
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of acute (1 day) and subchronic (28 days) treatment with three atypical antipsychotic drugs [clozapine, (+/-)-sulpiride and (-)-3-PPP] on dopamine and serotonin turnover in both the nucleus accumbens (NA) and corpus striatum (CS) of rodents was compared to haloperidol and saline treatment. The equivalent doses of all drugs were determined based upon their ability to compete in vivo for H-3-spiperone binding in the NA and CS. All three atypical drugs, compared to haloperidol, produced preferential elevations of dopamine turnover in the NA. Further, the development of tolerance to this effect was more apparent for the three atypical drugs than for haloperidol. Surprisingly, all three atypical drugs, but not haloperidol, produced changes in serotonin turnover, despite the fact that (+/-)-sulpiride and (-)-3-PPP have no known direct effects on brain serotonin systems. All three atypical drugs produced acute increases in serotonin turnover in both the NA and CS, followed by later decreases.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 38 条
[2]   CHRONIC TREATMENT WITH CLASSICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS DIFFERENTIALLY DECREASES DOPAMINE RELEASE IN STRIATUM AND NUCLEUS-ACCUMBENS INVIVO [J].
BLAHA, CD ;
LANE, RF .
NEUROSCIENCE LETTERS, 1987, 78 (02) :199-204
[3]   EFFECTS OF DOPAMINE ANTAGONISTS AND APOMORPHINE ON REGIONAL ENERGY-METABOLISM IN RAT CNS [J].
CARVEY, PM ;
BRAUN, AR ;
KAO, LC ;
KLAWANS, HL .
CLINICAL NEUROPHARMACOLOGY, 1987, 10 (03) :247-260
[4]  
COSTALL B, 1977, ADV BEHAV BIOL, V21, P47
[5]   SENSITIZATION VERSUS TOLERANCE TO THE DOPAMINE TURNOVER-ELEVATING EFFECTS OF HALOPERIDOL - THE EFFECT OF REGULAR INTERMITTENT DOSING [J].
CSERNANSKY, JG ;
BELLOWS, EP ;
BARNES, DE ;
LOMBROZO, L .
PSYCHOPHARMACOLOGY, 1990, 101 (04) :519-524
[6]   MECHANISMS OF ACTION OF ATYPICAL ANTIPSYCHOTIC-DRUGS - IMPLICATIONS FOR NOVEL THERAPEUTIC STRATEGIES FOR SCHIZOPHRENIA [J].
DEUTCH, AY ;
MOGHADDAM, B ;
INNIS, RB ;
KRYSTAL, JH ;
AGHAJANIAN, GK ;
BUNNEY, BS ;
CHARNEY, DS .
SCHIZOPHRENIA RESEARCH, 1991, 4 (02) :121-156
[7]   D1-DOPAMINE AND D2-DOPAMINE RECEPTOR OCCUPANCY DURING TREATMENT WITH CONVENTIONAL AND ATYPICAL NEUROLEPTICS [J].
FARDE, L ;
WIESEL, FA ;
NORDSTROM, AL ;
SEDVALL, G .
PSYCHOPHARMACOLOGY, 1989, 99 :S28-S31
[8]  
GOLDSTEIN A, 1974, PRINCIPLES DRUG ACTI, P82
[9]  
HALL H, 1989, CLIN PHARM PSYCHIATR, P123
[10]   3-PPP, A NEW CENTRALLY ACTING DA-RECEPTOR AGONIST WITH SELECTIVITY FOR AUTORECEPTORS [J].
HJORTH, S ;
CARLSSON, A ;
WIKSTROM, H ;
LINDBERG, P ;
SANCHEZ, D ;
HACKSELL, U ;
ARVIDSSON, LE ;
SVENSSON, U ;
NILSSON, JLG .
LIFE SCIENCES, 1981, 28 (11) :1225-1238